Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

4 Jan 2007 07:00

Tarsus Group PLC04 January 2007 4 January 2007 TARSUS GROUP PLC TRADING UPDATE Tarsus Group PLC ("Tarsus" or "the Group"), the international media group withinterests in exhibitions, conferences, publishing and online media has continuedto trade well in the second half of 2006. Trading for the full year remains inline with Directors' expectations notwithstanding significant US Dollar weaknessin the second half of our financial year. Like-for-like organic revenue growth was a healthy 14%, led by 2 of the Group'slargest events during the year - Labelexpo Americas and Heavent (France) - whichtraded above this overall level. The August Off-Price show once again producedrecord revenues which were slightly ahead of the 2005 result. Generally,attendances at our events in the second half were strong, particularly in Francewhich is benefiting from an improving economic environment. Revenues from emerging markets doubled on a like-for-like basis. We havecontinued to develop our Chinese portfolio throughout 2006 and expect this to bean area of further development in 2007. Caroo - our online business - trebled its revenues, boosted by the acquisitionsof Onrec and TSNN.com. Annualised revenues at Caroo are now running atapproximately £2 million. Elsewhere, Labels and Labelling magazine had anothergood year with revenues up by 10%. Our organic growth strategy has been supplemented by a small number of focusedacquisitions. In October we acquired Proseg, the leading annual facilitiesmanagement exhibition in Paris and then, in November, we announced the purchaseof 80% of Medical Conferences International Inc. (MCII). This was accompanied bya vendor placing of 5.3 million new ordinary shares at 207p, raisingapproximately £10.5 million after expenses. MCII is the leading anti-ageing andregenerative medicine conference and exhibition in the United States with annualevents in Las Vegas, Orlando and Chicago. A number of joint ventures toreplicate the event outside of the United States have been agreed for 2007. TheDecember Las Vegas event produced a strong performance with revenues andattendees up by 55% and 34% respectively, both slightly ahead of ourexpectations at the time of acquisition. Integration is proceeding well. MCII creates a fifth major division to our business and further adds to theorganic growth capability of the Group. Outlook for 2007 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. For 2007, we expect continuedgood levels of organic growth in our portfolio as a result of the increasedlevel of new product development that we have undertaken in the last two years,as well as from the recent acquisitions that we have completed. In 2007, our Labelexpo exhibition returns to Europe and, as a result, we expectour US$ denominated earnings to be nearer 50% of the Group's total earningscompared with approximately 90% in 2006. Forward booking for this - our largestsingle event - are strong. The underlying momentum of the business is positive and we continue to generatestrong cash flows which are being reinvested for further growth. Although we areat a very early stage of the year, the Directors are confident that 2007 will beanother year of strong progress for the Group. Ends For further information please contact: Tarsus Group plc: Douglas Emslie Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Mar 20114:31 pmRNSHolding(s) in Company
17th Mar 20114:28 pmRNSAcquisition
10th Mar 201112:00 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
21st Jan 201110:42 amRNSAdditional Listing
18th Jan 20114:36 pmRNSHolding(s) in Company
18th Jan 20114:36 pmRNSHolding(s) in Company
6th Jan 20117:00 amRNSTrading Statement
5th Jan 20114:29 pmRNSHolding(s) in Company
5th Jan 20114:27 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20103:02 pmRNSScrip Dividend Circular
30th Nov 20102:37 pmRNSTotal Voting Rights
16th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20104:58 pmRNSBlocklisting Interim Review
17th Sep 20104:55 pmRNSChange of Registered Office
31st Aug 20109:55 amRNSTotal Voting Rights
25th Aug 20106:14 pmRNSHolding(s) in Company
25th Aug 20106:12 pmRNSHolding(s) in Company
25th Aug 20106:11 pmRNSHolding(s) in Company
25th Aug 20106:09 pmRNSHolding(s) in Company
25th Aug 20106:07 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSCompletion of Acquisition and Total Voting Rights
20th Aug 20104:14 pmRNSDirector/PDMR Shareholding
19th Aug 20101:50 pmRNSResult of Meeting
18th Aug 201010:55 amRNSInterim Financial Statements 2010
17th Aug 201010:41 amRNSDirector/PDMR Shareholding
30th Jul 201010:53 amRNSTotal Voting Rights
28th Jul 20107:01 amRNSPosting of Circular
28th Jul 20107:00 amRNSInterim Results
26th Jul 20103:22 pmRNSApplication for Admission
5th Jul 20103:55 pmRNSApplication for admission
30th Jun 20107:00 amRNSPre-close Trading Statement
17th Jun 20105:10 pmRNSDirector/PDMR Shareholding
16th Jun 20102:48 pmRNSResult of AGM
7th Jun 20102:31 pmRNSCirc re. Scrip Dividend
14th May 201012:21 pmRNSAmendment to Notice of Annual General Meeting
10th May 20104:58 pmRNSAnnual Information Update
10th May 20107:00 amRNSInterim Management Statement
7th May 201011:14 amRNSBlocklisting Six Monthly Return
30th Apr 201010:05 amRNSTotal Voting Rights
13th Apr 20105:31 pmRNSDirector/PDMR Shareholding
12th Apr 20101:36 pmRNSAnnual Reports and Accounts
9th Apr 20104:44 pmRNSHolding(s) in Company
1st Apr 20104:33 pmRNSNotification of Interests in Shares
31st Mar 20109:48 amRNSTotal Voting Rights
8th Mar 20107:00 amRNSAcquisition
8th Mar 20107:00 amRNSFinal Results
5th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.